Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: melanocortin receptor modulators - Palatin Technologies

Drug Profile

Research programme: melanocortin receptor modulators - Palatin Technologies

Alternative Names: PL-8331; PL-8905; PL-9610; PL-9643; PT 18

Latest Information Update: 15 May 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Palatin Technologies
  • Class Anti-inflammatories; Antihyperglycaemics; Eye disorder therapies; Obesity therapies; Peptides; Skin disorder therapies; Small molecules
  • Mechanism of Action Melanocortin receptor agonists; Melanocortin type 1 receptor agonists; Melanocortin type 3 receptor agonists; Melanocortin type 4 receptor agonists; Melanocortin type 4 receptor antagonists; Melanocortin type 5 receptor agonists; Melanocortin type 5 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Diabetes mellitus; Dry eyes; Inflammatory bowel diseases; Obesity
  • No development reported Cachexia; Erythropoietic protoporphyria; Inflammation; Kidney disorders; Nephritis; Uveitis; Vitiligo

Most Recent Events

  • 12 Sep 2019 Palatin Technologies plans to file an IND application for PL 9643 with the US FDA for Dry eyes in the first quarter of 2020
  • 06 Aug 2019 Palatin Technologies plans a phase II trial of PL 9643 for Dry eyes in the first quarter of 2020
  • 01 Jul 2019 Palatin Technologies plans to file an IND application for PL 8905 in the first half of 2020
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top